Cargando…

SAT379 Potassium Levels in Women with PCOS Using Spironolactone for Long-term

Disclosure: T.A. Oliveira: None. L.B. Marchesan: None. P.M. Spritzer: None. Introduction. Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. Spironolactone (SPL) has been used off-label to manage hyperandrogenic manifestations in women with PCOS b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Thais Areias, Marchesan, Lucas Bandeira, Spritzer, Poli Mara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555040/ http://dx.doi.org/10.1210/jendso/bvad114.1684

Ejemplares similares

SUN-013 Cardiometabolic Profile of Brazilian Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Meta-Analysis
por: Marchesan, Lucas Bandeira, et al.
Publicado: (2020)

SAT382 Lean Mass and Associated Factors in Women with PCOS with Different Phenotypes
por: Fighera, Tayane Muniz, et al.
Publicado: (2023)

PMON246 Prevalence of Hypertension and Metabolic Syndrome in Women with PCOS from France and Brazil
por: Spritzer, Poli Mara, et al.
Publicado: (2022)

Are Vitamin D Deficiency and VDR Gene Polymorphisms Associated With Higher Blood Pressure Defined by the 2017 ACC/AHA in Postmenopausal Women?
por: dos Santos, Betânia Rodrigues, et al.
Publicado: (2021)

Lifestyle, Anxiety,Depression, and Clinical Profile in Women With Polycystic Ovary Syndrome: Initial Results From the Brazilian PCOS Study
por: Spritzer, Poli Mara, et al.
Publicado: (2021)

SAT-234 DBP Gene Polymorphisms in Adult and Postmenopausal Women: Association with DBP and Vitamin D Serum Levels
por: Santos, Betânia, et al.
Publicado: (2019)

Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review
por: Marchesan, Lucas Bandeira, et al.
Publicado: (2021)

SAT376 Luteinizing Hormone Secretion in Hyperandrogenic Girls Taking Spironolactone or Metformin
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2023)

Metabolic profile of women with PCOS in Brazil: a systematic review and meta-analysis
por: Spritzer, Poli Mara, et al.
Publicado: (2021)

SAT-222 Hormone Responses Associated with Letrozole Ovulation Induction in Anovulatory Women with PCOS
por: Hadnott, Tracy, et al.
Publicado: (2019)

Hirsutism, Normal Androgens and Diagnosis of PCOS
por: Spritzer, Poli Mara, et al.
Publicado: (2022)

THU256 Prevalence And Risk Factors Associated With Diabetes Mellitus Among Middle Aged Women In Southern Brazil: A Population Based Study
por: Oppermann, Karen, et al.
Publicado: (2023)

ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS
por: Ibanez, Lourdes, et al.
Publicado: (2022)

SAT-004 Prevalence of Abnormalities of Glucose Metabolism in Teenage Indian Girls with PCOS
por: Talwar, Vipan
Publicado: (2020)

ODP425 Potassium Level Trends in Trans Females Using Spironolactone: A Retrospective Chart Review
por: Gupta, Pranav, et al.
Publicado: (2022)

SAT358 Race And Ethnicity Of Women With 21-hydroxylase Deficient Non-classic Adrenal Hyperplasia (NCAH) Compared With PCOS
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

SAT374 Indirect and Intangible Burden of PCOS: A Patient Advocacy Organization Study
por: Thai, Linda, et al.
Publicado: (2023)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

SAT359 The Biochemical Investigation of PCOS: A UK Wide Survey of Laboratory Practice
por: Hawley, James, et al.
Publicado: (2023)

SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
por: Hatoum, Sana, et al.
Publicado: (2023)

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

SAT372 Obstructive Sleep Apnea (OSA) Risk Among Patients With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

SAT375 Impact of Flutamide on Wake vs. Sleep LH Pulse Frequency in PCOS: An Interim Analysis
por: Matingou, Cyrena K, et al.
Publicado: (2023)

SAT350 PCOS and the Diagnostic Experience: Results From a Diverse United States Cohort Study
por: Huddleston, Heather, et al.
Publicado: (2023)

SAT387 Impact Of Genetic Background On Chronic Inflammation In A Letrozole-induced Mouse Model Of PCOS
por: Ujagar, Naveena, et al.
Publicado: (2023)

Sleep Characteristics Among Women With and Without PCOS
por: Oppermann, Karen, et al.
Publicado: (2021)

FRI379 The Gonadotoxic Effects Of Cyclophosphamide And Busulfan On Ovaries In CD-1 Mouse Model
por: Thonen, Macy, et al.
Publicado: (2023)

SAT368 Severe Hyperandrogenism in a Young Woman with Elevated BMI: A Case Study of The Role of Weight Loss in The Management of PCOS
por: Ortega, Susel Rodriguez, et al.
Publicado: (2023)

THU650 Prevalence Of Hyperandrogenemia, PCOS And Obesity In Mothers Of Daughters With PCOS
por: Cai, Jie, et al.
Publicado: (2023)

SAT363 The Prevalence And Phenotype Of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population In Sub-Sahara Africa: The Nigeria-PEP Study
por: Makwe, Christian Chigozie, et al.
Publicado: (2023)

OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?
por: Gebara, Nour, et al.
Publicado: (2019)

PMON209 Ceramides Predict Metabolic Response to Metformin in Women with PCOS
por: Sharma, Anu, et al.
Publicado: (2022)

PSUN128 Insurance Database Analysis of Healthcare Utilization by Women with PCOS
por: Lawrence, Rebecca, et al.
Publicado: (2022)

SAT-227 Diet-Induced Obesity and Prenatal Androgen Exposure Reprogram the Fetus and Cause Transgenerational PCOS-Like Phenotypic Changes in Adult Female Offspring
por: Risal, Sanjiv, et al.
Publicado: (2019)

PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study
por: Balogun, Mobolanle, et al.
Publicado: (2022)

Metabolic PCOS Features Are Ameliorated by Mitochondrial Uncoupler BAM15 in a PCOS Mouse Model
por: Paris, Valentina Rodriguez, et al.
Publicado: (2021)

FRI427 Hypocaloric Dietary Intervention Reduces Excessive Follicle Recruitment In Women With PCOS
por: Carter, Faith, et al.
Publicado: (2023)

MON-022 Dissecting the Interplay Between Diet and PCOS Pathology on Gut Microbiota in a PCOS Mouse Model
por: Paris, Valentina Rodriguez, et al.
Publicado: (2020)

SAT386 Constitutive Overexpression Of Microrna-93 As A Cause Of Metabolic Dysfunction And Hyperandrogenism In Polycystic Ovary Syndrome (PCOS): Evidence From A Transgenic (Mir-93+) Murine Model
por: Chen, Yen-Hao, et al.
Publicado: (2023)

MON-034 Impact of Race and Obstructive Sleep Apnea on Glucose and Insulin Regulation in Women with PCOS
por: Temple, Karla A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hp105k9qrd34408uo52srmeh8a